Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027953	s-aldol	u/l (u/l)	2013	2902	0.03%
3027953	s-aldol	— (—)	503	587	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of the myoneural junction and muscle

293

216

14.31

317.44

1.8

1.4

8.81

6.41

u/l

1.14

239

183

Other soft tissue disorders, not elsewhere classified

819

943

5.15

315.16

1.5

1.3

5.49

6.05

u/l

0.69

687

787

Oral corticosteroids

944

1221

4.64

307.65

1.9

1.2

6.07

5.91

u/l

0.17

796

1016

Other systemic involvement of connective tissue (FG)

487

346

14.39

307.65

1.8

1.3

5.59

6.26

u/l

0.46

418

282

Symptoms and signs involving the nervous and musculoskeletal systems

678

1176

5.87

307.65

1.4

1.5

5.55

5.97

u/l

0.50

558

1005

Systemic connective tissue disorders

709

607

12.13

307.65

2.1

1.2

6.03

5.89

u/l

0.12

621

498

Other systemic involvement of connective tissue

497

472

10.90

307.65

1.8

1.2

5.58

5.96

u/l

0.31

428

387

ILD medications: immunosuppressive drugs

685

1030

6.27

307.65

2.1

1.1

6.13

6.12

u/l

0.01

604

857

ILD medications

929

1133

4.49

298.30

1.8

1.1

5.85

6.04

u/l

0.19

795

937

ILD medications: prednisolone, methylprednisolone, prednisone

900

1121

4.53

296.43

1.8

1.1

5.95

6.05

u/l

0.10

759

925

Inflammatory bowel disease treatment related agents

945

1251

4.26

290.11

1.8

1.2

6.11

5.90

u/l

0.23

796

1046

Myositis

162

56.52

283.33

3.2

1.3

9.35

5.58

u/l

3.48

155

Disorders of muscles

223

124

18.83

279.62

2.7

1.4

8.48

6.01

u/l

2.17

202

104

Myalgia

326

355

9.41

271.08

1.4

5.07

5.82

u/l

0.99

271

300

Reimbursement for rheumatic diseases

582

1217

4.83

256.41

2.2

1.2

5.88

5.77

u/l

0.13

509

1009

Autoimmune diseases related-to ILD

735

1533

4.14

255.11

1.9

1.2

6.05

5.83

u/l

0.26

628

1267

Other symptoms and signs involving the nervous and musculoskeletal systems

475

840

5.76

254.67

1.4

1.5

5.15

5.82

u/l

1.74

393

717

Other and unspecified myopathies

209

139

15.90

239.89

2.0

1.5

9.46

7.08

u/l

0.73

176

118

First line medication for Crohn's disease

840

1130

4.05

239.17

1.8

1.2

5.91

5.99

u/l

0.07

715

942

Pain in joint

503

531

6.11

237.68

1.4

1.5

5.18

6.73

u/l

2.82

419

450

L04AX Other immunosuppressants

566

1254

4.58

233.75

2.2

1.2

6.17

5.66

u/l

0.85

495

1049

Finngen Rheumatological endpoints

744

1001

4.26

230.33

1.7

1.2

5.79

6.22

u/l

0.47

644

818

Second line medication for Crohn's disease

572

1296

4.48

229.63

2.2

1.2

6.16

5.67

u/l

0.82

501

1079

Pain in limb

617

912

4.57

221.34

1.5

1.3

5.69

6.07

u/l

0.35

522

760

Mixed connective tissue disease

183

127

15.45

205.69

2.1

1.5

6.18

6.07

u/l

0.05

163

106

Polymyalgia rheumatica

198

175

11.69

191.23

1.5

1.2

5.18

6.40

u/l

0.64

165

147

Other specific joint derangements/joint disorders

592

921

4.19

189.19

1.4

1.5

5.22

6.58

u/l

2.54

495

759

Other specified/unspecified systemic involvement of connective tissue

155

17.59

186.84

2.0

1.2

5.70

5.72

u/l

0.01

139

Polymyositis

123.99

183.73

4.1

1.2

9.26

5.61

u/l

1.64

Autoimmune diseases excluding thyroid diseases

740

1170

3.48

173.18

1.9

1.2

6.31

5.72

u/l

0.76

642

971

Autoimmune diseases excluding thyroid diseases, strict definition

714

1132

3.48

167.56

1.9

1.2

6.36

5.72

u/l

0.80

618

942

Soft tissue disorders

662

948

3.62

160.25

1.6

1.3

6.01

6.05

u/l

0.03

558

792

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

126

35.06

151.94

2.1

1.0

6.19

5.39

u/l

0.47

116

Spondylopathies

549

885

3.74

147.01

1.4

5.76

6.37

u/l

0.56

464

747

Dorsalgia

654

1051

3.36

144.61

1.5

1.4

5.54

6.32

u/l

1.05

554

882

Malaise and fatigue

394

738

4.34

142.60

1.5

1.4

5.20

5.88

u/l

1.55

327

621

Low back pain

506

1025

3.57

135.88

1.4

5.52

6.35

u/l

0.98

426

860

Other dorsopathies, not elsewhere classified

649

1052

3.25

135.69

1.5

1.4

5.69

6.31

u/l

0.72

548

883

Abnormalities of gait and mobility

164

182

9.28

134.73

1.5

1.4

6.78

6.46

u/l

0.08

130

155

Neurological diseases, wide definition

188

15.10

134.52

1.6

1.0

6.28

5.09

u/l

0.87

155

Diseases of the musculoskeletal system and connective tissue

301

233

6.52

133.26

1.6

1.1

6.85

7.13

u/l

0.07

255

186

General symptoms and signs

688

1116

3.11

132.17

1.5

1.4

5.76

5.82

u/l

0.05

596

933

Other arthritis (FG)

253

467

5.49

129.68

1.5

1.3

5.59

6.34

u/l

0.68

216

388

Neurological diseases

516

723

3.61

123.38

1.6

1.4

6.07

5.53

u/l

0.57

441

603

Fever of other and unknown origin

388

916

3.80

121.89

1.7

1.4

5.98

5.85

u/l

0.13

322

772

Other intervertebral disc disorders

532

973

3.31

120.68

1.5

1.4

5.45

6.39

u/l

1.28

451

819

Dorsopathies

632

1060

3.05

118.50

1.5

1.4

5.75

6.33

u/l

0.64

541

890

Autoimmune diseases

670

1172

2.92

117.40

1.8

1.2

6.26

5.71

u/l

0.60

577

972

Polyarthropathies

455

844

3.55

117.38

1.6

1.4

5.67

6.72

u/l

1.44

387

696

Spondylosis

372

788

3.88

117.10

1.4

5.24

6.54

u/l

2.29

324

666

Other and unspecified polyneuropathies, also in other diseases

208

356

5.97

115.86

1.4

1.5

5.32

6.51

u/l

1.24

177

296

Polyneuropathies and other disorders of the peripheral nervous system

223

410

5.54

115.07

1.4

1.5

5.41

6.44

u/l

1.20

191

346

ILD medications: azathioprine

162

215

7.69

114.81

2.8

1.1

6.74

6.19

u/l

0.32

138

185

Fibromyalgia

128

130

10.13

112.32

1.3

1.4

4.78

5.81

u/l

1.88

108

111

Lower back pain or/and sciatica

682

1669

2.68

111.27

1.4

5.37

6.11

u/l

1.34

578

1391

Abnormalities of breathing

575

1136

2.96

107.66

1.5

6.43

5.69

u/l

0.67

490

955

Used for control exclusion in common control thyroid runs

616

1077

2.91

106.65

1.8

1.2

6.12

5.77

u/l

0.35

536

899

Azathioprine

162

235

7.03

106.06

2.8

1.2

6.74

5.89

u/l

0.63

138

202

Headache

421

1015

3.34

105.72

1.4

6.14

5.87

u/l

0.15

361

848

Sicca syndrome [Sjögren]

122

127

9.92

105.25

1.9

1.2

5.72

5.70

u/l

0.01

103

107

Other specified/unspecified arthritis

228

464

4.98

104.76

1.5

1.6

5.63

6.42

u/l

0.85

193

391

Sciatica+with lumbago

338

860

3.65

101.05

1.5

1.4

5.03

6.55

u/l

3.38

294

732

Pain (limb, back, neck, head abdominally)

396

548

3.64

95.95

1.4

1.5

6.07

6.68

u/l

0.44

346

465

Tramadol

502

1055

2.94

94.91

1.5

1.4

6.64

5.77

u/l

0.73

427

881

Care involving use of rehabilitation procedures

446

1427

2.90

91.63

1.7

1.4

5.46

5.99

u/l

0.97

376

1216

Spinal stenosis

313

641

3.74

91.59

1.4

6.08

6.32

u/l

0.12

266

537

Examination and observation for other reasons

371

616

3.51

90.38

1.4

5.74

5.96

u/l

0.19

303

523

Other joint disorders

512

939

2.89

89.41

1.4

1.5

5.20

6.56

u/l

2.58

439

773

Nerve, nerve root and plexus disorders

648

1608

2.48

89.08

1.6

1.4

5.82

5.95

u/l

0.12

542

1350

Dermatitis

410

1408

2.92

87.34

1.5

5.38

6.02

u/l

1.47

349

1177

Asthma, excluding more controls

463

802

3.03

86.97

1.5

1.3

5.30

5.86

u/l

1.12

387

683

Medical observation and evaluation for suspected diseases and conditions

401

618

3.34

86.85

1.4

6.51

5.97

u/l

0.39

342

525

Asthma

471

836

2.97

85.92

1.5

1.3

5.29

5.90

u/l

1.31

393

711

Pain, not elsewhere classified

214

487

4.44

85.82

1.6

1.4

5.12

5.92

u/l

1.67

180

412

Other and unspecified dermatitis

359

1165

3.11

85.20

1.5

5.40

5.95

u/l

1.11

309

977

Infections, IBD-co-morbidities

16.03

83.99

1.8

1.0

6.03

5.05

u/l

0.55

Arthropathies

517

945

2.79

83.56

1.5

5.88

6.56

u/l

0.64

441

779

Asthma (mode)

458

844

2.92

81.94

1.5

1.3

5.28

5.89

u/l

1.35

381

719

Shoulder lesions

399

785

3.10

81.93

1.4

1.3

5.58

6.13

u/l

0.57

346

659

Disorders of thyroid, IBD co-morbidities

14.16

81.16

1.4

1.0

5.96

5.05

u/l

0.56

Pain in throat and chest

488

1106

2.66

76.87

1.4

5.86

5.69

u/l

0.16

425

926

Abnormal involuntary movements

131

216

6.18

75.91

1.4

1.5

5.02

6.32

u/l

1.65

106

185

Other and unspecified primary disorders of muscles

40.35

75.11

1.5

1.6

7.40

8.33

u/l

0.11

Lumbar disc prolapse

360

929

2.99

74.99

1.5

1.4

5.67

6.43

u/l

0.70

303

786

L04AA Selective immunosuppressants

211

540

3.97

72.59

2.4

1.5

6.08

6.01

u/l

0.05

191

455

Other necrotizing vasculopathies

9.22

71.28

1.5

1.2

5.25

7.40

u/l

0.68

Symptoms and signs involving the skin and subcutaneous tissue

437

1691

2.54

71.05

1.4

1.5

5.48

6.02

u/l

0.65

372

1410

Asthma (only as main-diagnosis), excluding more controls

400

802

2.87

70.96

1.5

1.3

5.39

5.86

u/l

0.82

330

683

Other necrotizing vasculopathies (FG)

11.93

70.69

1.3

5.22

7.92

u/l

0.54

Symptoms and signs involving the circulatory and respiratory systems

553

1140

2.44

69.41

1.5

5.87

5.69

u/l

0.17

467

958

Dyspnoea

525

1648

2.37

68.68

1.5

1.4

6.16

5.89

u/l

0.22

451

1369

Asthma (only as main-diagnosis)

402

836

2.80

68.61

1.5

1.3

5.40

5.90

u/l

0.92

332

711

Codeine

514

1138

2.47

67.56

1.5

1.4

5.58

5.73

u/l

0.22

444

946

Opioids

536

1151

2.43

67.41

1.4

5.90

5.73

u/l

0.15

451

957

Dermatopolymyositis, unspecified

170.27

66.98

3.9

1.2

6.44

5.60

u/l

—

Other/unspecified dorsalgia

224

624

3.59

66.97

1.4

5.66

5.89

u/l

0.12

188

529

Rotator cuff syndrome

311

736

3.05

65.81

1.4

1.3

5.50

6.20

u/l

0.69

264

619

Asthma, unspecified (mode), excluding more controls

305

750

3.06

65.76

1.5

1.3

5.31

5.90

u/l

1.05

248

638

Dermatitis and eczema

616

1741

2.20

65.48

1.5

1.4

5.44

6.05

u/l

1.11

525

1449

Asthma, unspecified (mode)

310

781

3.01

64.98

1.5

1.3

5.33

5.94

u/l

1.15

250

665

ILD, hospital admissions

139

281

5.03

64.67

2.0

1.5

6.09

6.65

u/l

0.33

124

236

ILD, hospital admissions 1, main diag only

128

242

5.39

64.27

2.1

1.5

5.91

6.72

u/l

0.46

114

202

SLE (Finngen)

13.53

64.27

1.9

1.1

5.90

6.06

u/l

0.04

Other interstitial pulmonary diseases

139

286

4.94

63.35

2.0

1.5

6.09

6.64

u/l

0.32

124

239

Interstitial lung disease

139

286

4.94

63.35

2.0

1.5

6.09

6.63

u/l

0.31

124

239

Interstitial lung disease endpoints

139

286

4.94

63.35

2.0

1.5

6.09

6.63

u/l

0.31

124

239

Asthma-related infections

357

1327

2.65

63.21

1.5

1.4

5.39

5.95

u/l

1.35

296

1124

Asthma, hospital admission 2, infections

357

1327

2.65

63.21

1.5

1.4

5.39

5.95

u/l

1.35

296

1124

295

1009

2.92

62.96

1.6

1.4

5.36

6.08

u/l

1.51

247

867

General examination and investigation of persons without complaint and reported diagnosis

345

617

2.93

61.77

1.3

1.4

5.57

5.97

u/l

0.25

295

524

Episodal and paroxysmal disorders

591

1355

2.23

61.20

1.5

5.52

5.89

u/l

0.51

503

1124

Other respiratory diseases principally affecting the interstitium

148

331

4.54

60.92

2.0

1.6

6.06

6.82

u/l

0.54

131

277

Persons encountering health services for specific procedures and health care

597

1661

2.16

60.35

1.6

1.4

5.92

5.88

u/l

0.04

498

1402

Rheumatism, unspecified

109

192

5.76

59.03

1.4

1.5

4.83

6.33

u/l

1.21

158

Other pulmonary diagnosis

427

843

2.55

58.58

1.6

1.3

6.05

5.90

u/l

0.10

360

717

Excluding asthma or asthma-COPD overlap

424

843

2.53

57.38

1.6

1.3

6.10

5.90

u/l

0.14

357

717

Systemic lupus erythematosus

11.15

56.89

1.9

1.2

5.90

6.37

u/l

0.17

Diseases of oesophagus, stomach and duodenum

582

1638

2.13

56.83

1.4

5.97

5.90

u/l

0.05

483

1388

Hypothyroidism (congenital or acquired)

157

186

4.80

55.97

1.7

1.4

5.21

5.12

u/l

0.08

127

168

ILD, hospital admission 2, with pulmonary infections

145

6.46

55.82

2.2

1.4

6.32

6.47

u/l

0.06

124

Migraine

307

913

2.74

55.74

1.4

1.5

4.85

5.87

u/l

3.11

254

765

Asthma (diagnoses ohter than nonallergic)

484

1824

2.21

55.70

1.5

5.30

6.08

u/l

2.38

397

1534

Symptoms and signs concerning food and fluid intake

145

6.44

55.67

1.4

6.56

7.11

u/l

0.13

124

Anaemias

140

184

5.01

55.59

1.4

1.5

5.21

5.20

u/l

0.00

118

167

Abnormal findings on examination of blood, without diagnosis

289

961

2.78

55.40

1.8

1.4

5.99

6.19

u/l

0.19

242

814

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

171

187

4.61

55.32

1.5

1.3

6.55

6.02

u/l

0.24

143

165

ILD differential diagnosis

419

844

2.50

55.27

1.5

1.3

6.12

5.89

u/l

0.16

352

719

COPD differential diagnosis

418

845

2.49

54.76

1.5

1.3

6.12

5.90

u/l

0.15

351

720

Hypothyroidism and >3 levothyroxin purchases

155

186

4.74

54.60

1.7

1.4

5.27

5.12

u/l

0.14

125

168

Hypothyroidism, levothyroxine purchases

155

186

4.74

54.60

1.7

1.4

5.27

5.12

u/l

0.14

125

168

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

535

1734

2.14

54.35

1.6

1.4

5.74

5.99

u/l

0.28

442

1468

475

1271

2.27

54.15

1.7

1.4

6.32

5.94

u/l

0.32

393

1063

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

475

1271

2.27

54.15

1.7

1.4

6.32

5.94

u/l

0.32

393

1063

Cardiovascular diseases

345

691

2.70

53.97

1.5

6.00

5.38

u/l

0.76

298

589

Codeine or tramadol medication

601

1593

2.07

53.28

1.5

1.4

5.89

5.93

u/l

0.04

516

1323

Other antidepressants

545

1294

2.17

52.99

1.4

1.5

5.65

6.07

u/l

0.51

459

1083

Anxiety disorders, excluding more controls

460

1331

2.26

52.71

1.5

5.59

5.83

u/l

0.18

392

1122

Mood disorders, excluding more controls

510

1402

2.18

52.58

1.5

1.4

6.00

5.85

u/l

0.10

413

1179

Disturbances of skin sensation

205

638

3.25

52.53

1.2

1.5

4.75

5.75

u/l

3.13

174

542

Diseases of the skin and subcutaneous tissue

515

1174

2.21

52.15

1.5

1.4

5.86

6.23

u/l

0.31

440

978

Disorders of synovium and tendon

255

779

2.88

51.81

1.4

1.3

5.52

6.20

u/l

0.58

218

650

Systemic atrophies primarily affecting the central nervous system

9.72

51.80

1.1

1.5

5.39

8.64

u/l

0.63

Somatoform disorder

143

355

4.09

51.45

1.5

1.4

5.11

6.47

u/l

1.50

125

293

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

367

1384

2.39

51.25

1.6

1.4

6.39

5.83

u/l

0.45

317

1161

Dysphagia

171

482

3.58

51.22

1.7

1.4

5.69

6.53

u/l

0.67

148

404

Any reimbursement code in KELA

307

553

2.80

50.07

1.6

1.2

6.29

5.82

u/l

0.30

265

472

Mood [affective] disorders

550

1743

2.05

49.73

1.4

1.5

5.99

5.88

u/l

0.07

444

1482

Influenza and pneumonia

562

1760

2.04

49.61

1.7

1.4

6.18

5.73

u/l

0.54

469

1484

Mood disorders

550

1744

2.05

49.42

1.4

1.5

5.99

5.88

u/l

0.07

444

1483

Cervical disc disorders

196

616

3.20

49.37

1.3

1.4

5.17

5.97

u/l

2.04

162

523

Any gastric operation

409

870

2.37

48.42

1.6

1.3

6.41

5.54

u/l

0.89

344

749

GASTRO-related operations

409

870

2.37

48.42

1.6

1.3

6.41

5.54

u/l

0.89

344

749

Parasetamol

376

780

2.45

48.09

1.6

1.4

6.21

5.92

u/l

0.20

317

665

Other special examinations and investigations of persons without complaint or reported diagnosis

322

618

2.65

47.88

1.5

1.4

5.78

5.97

u/l

0.15

278

525

Cervicobrachial syndrome

139

356

3.94

47.86

1.3

1.4

5.57

6.01

u/l

0.28

117

305

Metabolic disorders

503

1468

2.10

47.52

1.4

6.10

5.83

u/l

0.26

419

1239

Neurotic, stress-related and somatoform disorders

488

1635

2.10

47.51

1.5

5.56

5.91

u/l

0.30

414

1380

Non-invasive ventilation

147

346

3.82

47.03

1.6

1.4

7.14

5.50

u/l

0.76

124

296

Anxiety disorders

490

1644

2.09

47.00

1.5

5.57

5.90

u/l

0.29

416

1385

Depression

512

1699

2.05

46.66

1.4

1.5

5.86

u/l

0.00

414

1447

Asthma, including avohilmo

606

1748

1.95

46.25

1.5

5.47

6.05

u/l

0.83

503

1473

Other enthesopathies

162

472

3.46

46.13

1.2

1.3

4.96

5.66

u/l

1.21

137

405

Other headache syndromes

243

901

2.71

45.40

1.3

1.4

4.94

5.94

u/l

3.00

211

752

Symptoms and signs involving cognition, perception, emotional state and behaviour

506

1708

2.03

44.84

1.4

6.52

5.75

u/l

0.60

429

1429

Abdominal and pelvic pain

499

1203

2.09

44.37

1.4

1.5

5.51

6.17

u/l

1.10

417

1022

Antihypertensive medication - note that there are other indications

328

700

2.49

44.13

1.6

1.4

6.39

5.59

u/l

0.74

282

591

COPD/asthma related infections

519

1271

2.05

43.93

1.6

1.4

6.07

5.94

u/l

0.10

438

1063

COPD/asthma/ILD related infections

519

1271

2.05

43.93

1.6

1.4

6.07

5.94

u/l

0.10

438

1063

Hypothyroidism, strict autoimmune

335

927

2.39

43.74

1.4

1.2

5.94

5.65

u/l

0.22

270

763

Rheumatoid arthritis

174

484

3.25

43.65

1.8

1.6

5.61

6.24

u/l

0.74

148

403

Giant cell arteritis

9.73

43.48

1.1

5.20

8.25

u/l

0.50

Symptoms and signs involving the digestive system and abdomen

497

1203

2.08

43.44

1.6

1.5

5.62

6.17

u/l

0.81

424

1022

L04AD Calcineurin inhibitors

106

241

4.48

42.94

3.0

1.5

6.24

7.18

u/l

0.43

203

Oedema, not elsewhere classified

173

543

3.16

42.63

1.7

1.4

6.56

6.00

u/l

0.25

146

448

Chronic lower respiratory diseases

610

1715

1.90

42.45

1.5

5.86

5.94

u/l

0.07

502

1454

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

134

5.86

42.39

1.6

1.4

6.12

7.20

u/l

0.36

114

Depression medications

154

196

3.97

42.18

1.6

6.12

5.13

u/l

0.74

133

177

Small fibre neuropathy

9.83

41.80

1.5

1.3

5.50

6.37

u/l

0.36

Gastro-oesophageal reflux disease

362

1429

2.20

41.50

1.4

5.25

5.95

u/l

1.46

298

1224

All pneumoniae

521

1790

1.95

41.43

1.6

1.4

6.24

5.73

u/l

0.58

431

1511

Deforming dorsopathies

152

457

3.35

41.26

1.8

1.5

4.84

5.94

u/l

2.89

130

385

Cervicalgia

121

313

3.90

41.15

1.4

1.5

5.63

6.09

u/l

0.31

101

264

Gonarthrosis [arthrosis of knee](FG)

315

760

2.42

40.97

1.4

1.2

5.71

6.43

u/l

0.63

266

622

SLE, ICD10

7.97

40.61

1.8

1.4

5.65

6.79

u/l

0.51

SLE, strict definition

7.97

40.61

1.8

1.4

5.65

6.79

u/l

0.51

Soft tissue disorders related to use, overuse and pressure

139

399

3.51

40.57

1.6

1.3

5.11

5.95

u/l

1.19

117

336

Pneumonias (Asthma/COPD co-morbidities)

515

1786

1.94

40.45

1.7

1.4

6.23

5.74

u/l

0.54

428

1505

Cramp and spasm

7.01

40.42

1.3

1.5

5.30

8.52

u/l

0.97

Raynaud syndrome

181

4.96

40.31

1.4

1.6

5.63

6.78

u/l

0.49

154

Abnormal findings on diagnostic imaging of lung

262

1022

2.47

40.25

1.7

1.5

6.19

6.08

u/l

0.06

231

844

Pain in thoracic spine

221

4.48

40.03

1.3

1.5

5.29

5.87

u/l

0.63

189

Hypertensive diseases (excluding secondary)

293

692

2.47

39.84

1.6

1.4

6.06

5.41

u/l

0.52

254

597

Dizziness and giddiness

391

1476

2.11

39.82

1.4

1.5

6.22

5.77

u/l

0.32

332

1234

Disorders of other endocrine glands

256

1023

2.48

39.70

1.5

5.62

5.92

u/l

0.19

215

857

Persons encountering health services in other circumstances, wide

578

1575

1.90

39.63

1.5

6.06

5.95

u/l

0.07

501

1314

Persons encountering health services for other counselling and medical advice, not elsewhere classified

551

1574

1.91

39.13

1.4

1.5

5.20

5.95

u/l

2.00

477

1314

Implicit Sepsis

387

1394

2.10

38.73

1.5

1.4

7.17

5.56

u/l

1.08

326

1182

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

500

1775

1.93

38.57

1.7

1.4

6.65

5.73

u/l

0.89

415

1500

Cardiovascular diseases (excluding rheumatic etc)

338

859

2.27

38.24

1.6

1.4

6.27

5.47

u/l

0.75

293

729

Vocal cord dysfunction

141

5.20

38.08

1.6

1.1

5.79

5.88

u/l

0.04

116

Other peripheral vascular diseases

152

5.23

38.02

1.3

1.6

5.68

5.95

u/l

0.12

131

Cardiac arrhythmias

325

940

2.26

37.39

1.4

6.07

5.40

u/l

0.65

278

796

Temporal arteritis

9.64

37.26

1.2

1.1

5.32

5.28

u/l

0.02

Disorders of eyelid, lacrimal system and orbit

432

1657

1.99

37.23

1.5

1.4

5.14

6.00

u/l

3.03

346

1394

Carpal tunnel syndrome

316

1272

2.20

36.65

1.5

1.4

5.91

5.78

u/l

0.12

270

1069

Methotrexate

200

4.50

36.55

2.0

1.2

5.73

5.65

u/l

0.04

173

Arthrosis

324

783

2.28

36.47

1.4

6.61

6.73

u/l

0.06

280

649

Certain infectious and parasitic diseases

469

1192

1.98

36.08

1.5

1.4

6.42

5.65

u/l

0.78

401

1010

Asthma/COPD (KELA code 203)

476

1712

1.91

35.99

1.4

1.5

5.19

5.94

u/l

2.67

390

1451

Persons encountering health services for examination and investigation

294

618

2.39

35.87

1.5

1.4

6.36

5.97

u/l

0.22

256

525

Pneumonia, organism unspecified

451

1635

1.94

35.73

1.6

1.4

6.42

5.77

u/l

0.53

373

1382

Asthma, hospital admissions , main diagnosis only

414

1865

1.97

35.62

1.5

5.40

6.03

u/l

1.67

342

1568

Intracranial trauma

224

611

2.59

35.35

1.7

1.4

7.49

5.66

u/l

0.85

192

518

Other disorders of adrenal gland

7.02

35.30

1.6

1.3

7.76

6.80

u/l

0.13

Other specified disorders of muscle

10.58

35.26

1.8

1.3

8.43

5.49

u/l

0.72

Other disorders of lacrimal gland

207

808

2.58

35.16

1.5

1.4

5.13

6.18

u/l

2.12

167

682

Systemic lupus erythematosus, unspecified

7.83

35.03

1.9

1.4

5.65

6.82

u/l

0.47

Recurrent or chronic depression

221

603

2.59

34.93

1.2

1.6

6.69

5.83

u/l

0.30

177

513

Implicit Sepsis

408

1508

1.99

34.82

1.5

1.4

7.21

5.50

u/l

1.27

345

1278

Irritable bowel syndrome

171

610

2.82

34.67

1.4

1.5

4.94

6.08

u/l

1.93

136

513

Obesity related asthma

204

797

2.58

34.59

1.5

1.4

5.45

6.18

u/l

1.20

177

687

540

1521

1.84

33.98

1.5

1.4

5.23

6.24

u/l

2.74

451

1272

Disorders of lacrimal system

235

987

2.39

33.89

1.5

1.4

5.01

5.98

u/l

2.45

193

832

Hypertension, essential

404

1140

2.01

33.81

1.5

1.4

5.93

5.98

u/l

0.04

350

967

Condition for Implicit Sepsis (Organ dysfunction codes)

442

1597

1.91

33.61

1.5

1.4

6.88

5.45

u/l

1.25

375

1345

Cough

204

760

2.55

33.61

1.6

1.5

4.74

5.65

u/l

3.15

160

643

Trochanteric bursitis

194

4.37

33.36

1.3

1.5

4.82

6.34

u/l

1.23

157

ILD, hospital admissions 3, with pneumonia sepsis

140

5.08

33.15

2.3

1.6

6.23

6.55

u/l

0.13

123

Depression or dysthymia

328

837

2.17

33.08

1.5

5.79

6.11

u/l

0.24

275

704

Diseases of the respiratory system

309

690

2.25

33.03

1.5

1.3

6.52

5.96

u/l

0.34

261

583

Abnormalities of heart beat

176

641

2.71

32.86

1.3

1.5

6.12

5.85

u/l

0.10

139

543

Concussion

193

602

2.63

32.64

1.8

1.4

7.02

5.66

u/l

0.57

167

512

Bacterial infection, other or unspecified

293

1148

2.17

32.57

1.6

1.4

6.80

5.92

u/l

0.49

244

968

Other diseases of intestines

511

1594

1.83

32.36

1.4

1.5

5.43

6.20

u/l

1.27

436

1346

Polyarthrosis

108

280

3.61

32.33

1.3

1.7

5.21

6.57

u/l

1.27

228

Other bacterial diseases

494

1717

1.83

32.22

1.5

1.4

6.98

5.67

u/l

1.30

415

1446

Diseases of the eye and adnexa

398

996

2.01

32.05

1.5

5.05

6.44

u/l

3.46

334

858

Giant cell arteritis with polymyalgia rheumatica

7.95

32.03

1.2

5.32

6.41

u/l

0.57

Condition for Implicit Sepsis (Organ dysfunction codes)

419

1554

1.91

31.81

1.5

1.4

7.39

5.49

u/l

1.44

353

1316

Other arthrosis

236

685

2.40

31.71

1.4

1.5

6.39

7.00

u/l

0.29

195

567

Other arrhythmias

333

1225

2.06

31.70

1.4

6.61

5.62

u/l

0.69

287

1038

Hypothyroidism, drug reimbursement

127

4.65

31.57

1.4

6.64

5.05

u/l

1.10

115

Adrenocortical insufficiency

7.22

31.49

1.4

7.93

6.32

u/l

0.21

Migraine without aura

124

391

3.20

31.30

1.5

1.4

4.56

5.96

u/l

2.93

108

333

Bacterial infection, other or unspecified

269

1069

2.19

30.99

1.7

1.4

6.99

5.88

u/l

0.60

223

898

Weight loss

189

4.30

30.94

1.4

1.6

5.12

7.19

u/l

1.44

164

Undetermined asthma

197

4.20

30.93

1.6

1.4

5.01

6.50

u/l

1.60

173

Other neurological diseases

349

1378

2.00

30.89

1.4

1.5

5.77

5.92

u/l

0.09

292

1160

Certain infectious and parasitic diseases

346

833

2.09

30.86

1.4

1.5

6.25

5.62

u/l

0.51

290

705

Undetermined asthma, excluding more controls

198

4.18

30.73

1.6

1.4

5.01

6.38

u/l

1.42

171

Other heart diseases

247

697

2.32

30.57

1.6

1.4

6.39

5.48

u/l

0.68

206

600

Asthma-related pneumonia or sepsis

189

756

2.51

30.41

1.5

5.38

6.28

u/l

1.54

153

631

Asthma, hospital admissions 3, pneumonia

189

756

2.51

30.41

1.5

5.38

6.28

u/l

1.54

153

631

Any mental disorder

513

1427

1.81

30.25

1.5

1.4

6.02

5.86

u/l

0.13

446

1199

Acute upper respiratory infections

487

1666

1.81

30.24

1.5

1.4

5.20

6.17

u/l

2.84

403

1397

Migraine with aura

140

483

2.92

30.24

1.5

1.4

5.15

6.23

u/l

1.47

114

405

Other heart diseases, wide

452

1501

1.85

30.11

1.5

1.4

5.97

5.81

u/l

0.14

385

1271

Extrapyramidal and movement disorders

201

834

2.43

30.05

1.4

1.5

5.38

6.22

u/l

1.23

168

693

Asthma-related pneumonia

188

756

2.50

29.93

1.5

5.38

6.28

u/l

1.53

152

631

Endocrine, nutritional and metabolic diseases

383

982

1.98

29.88

1.5

5.99

5.93

u/l

0.04

325

836

Complications of surgical and medical care, not elsewhere classified

472

1802

1.80

29.63

1.4

6.40

5.79

u/l

0.46

391

1506

Immunodeficiencies

6.14

29.44

1.8

1.4

4.52

6.74

u/l

1.63

Implicit viral Sepsis

161

607

2.67

29.40

1.7

1.4

6.48

5.64

u/l

0.30

132

513

Sleep apnoea

453

1614

1.82

29.32

1.5

1.4

5.75

6.01

u/l

0.26

389

1355

Immunodeficiency with predominantly antibody defects

8.55

29.27

1.7

1.4

4.54

7.93

u/l

1.27

Visual disturbances

254

1177

2.17

29.27

1.4

1.5

5.80

6.04

u/l

0.11

202

1001

Sleep apnoea, including avohilmo

477

1648

1.80

29.25

1.5

1.4

5.73

6.04

u/l

0.32

406

1383

Hypertension

394

1164

1.92

28.82

1.5

1.4

5.97

5.96

u/l

0.00

341

988

Oxicams

116

188

3.52

28.73

1.3

1.5

4.89

6.88

u/l

1.73

155

Hypertensive diseases

394

1166

1.91

28.70

1.5

1.4

5.97

5.96

u/l

0.00

341

990

Abnormal weight loss

175

4.29

28.62

1.4

1.6

5.18

7.30

u/l

1.36

154

Urticaria and erythema

208

898

2.33

28.46

1.5

5.46

6.03

u/l

0.64

176

759

Sleep disorders (combined)

513

1535

1.76

28.16

1.5

5.93

5.98

u/l

0.03

437

1278

Spondylopathies (FG)

203

3.98

28.10

1.4

1.3

5.07

6.54

u/l

0.85

170

Other disorders of urethra and urinary system

333

1224

1.97

27.94

1.4

1.5

5.89

5.92

u/l

0.02

277

1008

Other functional intestinal disorders

221

914

2.25

27.64

1.4

1.5

5.09

6.17

u/l

2.55

184

773

Coxarthrosis [arthrosis of hip](FG)

200

587

2.41

27.34

1.3

5.27

6.46

u/l

1.37

175

480

Osteopathies and chondropathies

278

1270

2.05

27.27

1.5

1.4

5.47

5.84

u/l

0.44

234

1075

All anxiety disorders

311

1242

1.99

27.19

1.4

1.5

5.89

5.93

u/l

0.02

258

1054

Seropositive rheumatoid arthritis

106

330

3.22

27.17

1.8

1.3

5.28

6.42

u/l

0.88

265

Anxiety (asthma-related co-morbidities)

302

1167

2.01

27.16

1.4

1.5

5.92

5.56

u/l

0.19

250

1002

Diarrhoea and gastroenteritis of presumed infectious origin

341

1617

1.91

27.09

1.4

1.5

5.32

6.00

u/l

1.68

279

1364

Bronchitis

498

1817

1.73

27.01

1.5

1.4

5.38

6.07

u/l

1.77

417

1521

Visual disturbances and blindness

260

1254

2.08

27.00

1.4

1.5

5.77

6.09

u/l

0.16

205

1063

Complications of medical and surgical care

351

1723

1.88

26.82

1.3

1.5

6.01

5.90

u/l

0.06

286

1450

Intestinal infectious diseases

441

1898

1.77

26.73

1.4

1.5

5.47

6.01

u/l

1.09

363

1604

Complications of procedures, not elsewhere classified

386

1753

1.83

26.55

1.4

6.33

5.81

u/l

0.32

325

1469

Follow-up examination after treatment for conditions other than malignant neoplasms

191

521

2.44

26.39

1.6

1.4

5.37

6.11

u/l

1.38

163

442

Coxibs

124

203

3.23

26.37

1.4

1.5

7.15

7.12

u/l

0.01

106

167

Certain disorders involving the immune mechanism

125

438

2.88

26.37

1.7

1.5

5.12

6.39

u/l

1.66

104

378

Other localized connective tissue disorders

8.65

26.31

1.7

1.4

5.34

7.77

u/l

0.70

Other bacterial diseases

441

1681

1.77

26.14

1.6

1.4

7.16

5.66

u/l

1.36

370

1422

Radiculopathy

233

3.63

26.01

1.3

1.5

5.05

6.40

u/l

1.69

194

Brachial plexus disorders

189

3.97

25.84

1.3

1.5

4.98

6.94

u/l

1.35

164

Intestinal infectious diseases

527

1785

1.69

25.76

1.3

1.5

5.73

5.96

u/l

0.20

436

1503

Gastrointestinal diseases

278

662

2.11

25.63

1.6

1.5

6.34

5.99

u/l

0.18

233

556

Non-allergic asthma (mode)

300

3.26

25.58

1.7

1.4

4.99

6.60

u/l

1.85

263

Gonarthrosis

266

720

2.11

25.45

1.4

1.5

5.89

6.80

u/l

0.79

225

595

Non-allergic asthma (mode), excluding more controls

301

3.25

25.45

1.7

1.4

4.99

6.48

u/l

1.64

261

Acute sinusitis

258

1170

2.05

25.40

1.4

5.03

6.23

u/l

3.02

217

999

Enthesopathies of lower limb, excluding foot

107

351

3.07

25.35

1.5

1.4

5.08

5.98

u/l

1.61

299

Implicit viral Sepsis

117

404

2.92

25.35

1.7

1.5

6.90

6.02

u/l

0.22

336

Viral Sepsis

117

404

2.92

25.35

1.7

1.5

6.90

6.02

u/l

0.22

336

Rheumatoid arthritis, including avohilmo

203

913

2.24

25.29

1.7

1.4

5.48

6.05

u/l

0.91

171

764

Hypermobility syndrome

5.69

25.25

1.1

1.2

4.60

5.66

u/l

0.75

Non-selective monoamine reuptake inhibitors

186

775

2.32

25.25

1.4

4.92

5.87

u/l

2.38

157

654

Chronic rhinitis, nasopharyngitis and pharyngitis

175

742

2.37

25.03

1.3

1.5

5.21

6.24

u/l

2.02

135

648

Thyroiditis, ILD-related definition

207

3.76

25.01

1.4

1.2

4.66

5.82

u/l

0.78

176

Other anxiety disorders

233

957

2.12

24.75

1.4

1.5

6.38

5.95

u/l

0.17

192

810

Spondylolisthesis/Spondylolysis

286

3.28

24.57

1.5

4.84

6.15

u/l

2.35

242

Acute upper respiratory infections of multiple and unspecified sites

348

1396

1.85

24.55

1.4

5.40

6.12

u/l

1.52

288

1183

Heart failure, not strict

348

1273

1.86

24.49

1.7

1.4

6.43

5.74

u/l

0.59

290

1074

Chronic sinusitis

217

1018

2.14

24.28

1.7

1.4

4.99

5.92

u/l

2.76

187

877

Other general symptoms and signs

6.12

24.25

1.4

1.3

5.56

7.14

u/l

0.71

Disorders of lipoprotein metabolism and other lipidaemias

367

1243

1.83

24.13

1.5

1.4

6.18

5.86

u/l

0.25

317

1049

Symptoms and signs involving speech and voice

179

780

2.31

24.09

1.3

1.5

4.87

6.21

u/l

3.35

148

664

Hypothyroidism, other/unspecified

410

1537

1.76

23.84

1.4

1.5

5.83

5.80

u/l

0.03

329

1298

Oxycodone

166

630

2.39

23.83

1.4

6.46

6.11

u/l

0.13

140

522

Other diseases of upper respiratory tract

493

1521

1.69

23.79

1.6

1.4

5.61

6.03

u/l

0.63

401

1287

Enlarged lymph nodes

272

3.30

23.77

1.5

1.4

7.81

6.16

u/l

0.38

226

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

253

1231

2.00

23.68

1.5

1.4

6.26

6.17

u/l

0.03

201

1053

Hypothyreosis and Thyroxine purchase for inclusion criteria

423

1600

1.74

23.63

1.4

1.5

5.81

5.87

u/l

0.05

341

1347

Other and unspecified nerve root and plexus disorders, also in other diseases

116

415

2.82

23.59

1.8

1.4

5.42

6.32

u/l

0.91

354

Rash and other nonspecific skin eruption

175

3.93

23.52

1.6

1.5

7.58

6.23

u/l

0.23

146

Dental caries

133

490

2.62

23.44

1.8

1.4

6.23

6.72

u/l

0.18

113

399

Disorders of the thyroid gland

430

1626

1.73

23.39

1.4

1.5

6.24

5.77

u/l

0.38

349

1371

Psychiatric diseases

443

1280

1.74

23.21

1.5

6.21

5.83

u/l

0.29

385

1074

Cerebral palsy and other paralytic syndromes

223

3.54

23.16

1.2

1.6

4.93

6.97

u/l

1.65

193

Spondyloarthritis

312

3.10

23.16

1.3

5.03

5.73

u/l

0.63

266

Constipation

405

1611

1.75

23.15

1.5

5.96

5.85

u/l

0.08

336

1362

Other disorders of skin and subcutaneous tissue

319

1541

1.85

23.00

1.7

1.4

5.91

5.89

u/l

0.02

260

1300

Implicit fungal Sepsis

123

4.54

22.90

1.2

1.4

8.28

5.86

u/l

0.39

105

Disorders of conjunctiva

385

1774

1.75

22.74

1.4

1.5

5.20

5.91

u/l

2.24

320

1494

Other disorders of fluid, electrolyte and acid-base balance

149

583

2.45

22.68

1.4

1.6

6.14

5.94

u/l

0.11

117

484

Caries of dentine

120

434

2.71

22.54

1.8

1.4

6.22

6.49

u/l

0.09

101

352

Voice disturbances

150

625

2.42

22.40

1.3

1.5

4.91

6.18

u/l

2.44

124

533

Diarrhoea and gastroenteritis of presumed infectious origin

455

1792

1.68

22.40

1.3

1.5

5.60

5.94

u/l

0.31

371

1511

Osteoporosis

132

483

2.57

22.18

1.6

1.5

5.77

6.40

u/l

0.35

116

395

Other reaction to severe stress, and adjustment disorders

186

854

2.19

22.09

1.4

1.5

6.46

6.03

u/l

0.14

160

719

Pure hypercholesterolaemia

320

1130

1.85

22.09

1.4

6.36

5.95

u/l

0.29

275

953

Biological medication for rheuma

112

408

2.77

22.06

1.3

1.5

5.50

6.49

u/l

0.92

351

Cerebral cysts

4.93

22.04

1.6

1.5

5.67

8.29

u/l

0.66

Conjunctivitis

354

1676

1.77

22.01

1.4

1.5

5.21

5.90

u/l

2.00

291

1414

Localized scleroderma [morphea]

9.11

21.70

1.4

5.50

8.52

u/l

0.63

Urticaria

167

744

2.26

21.39

1.5

5.52

5.98

u/l

0.38

139

625

Other specified/unspecified inflammatory spondylopathies

6.06

21.24

1.3

1.6

5.32

6.26

u/l

0.52

Other diseases of urinary system

441

1478

1.68

21.18

1.3

1.5

6.11

5.91

u/l

0.11

377

1235

Migraine with aura and triptan purchases

329

2.94

21.18

1.3

1.5

5.10

5.58

u/l

0.57

282

Hallux valgus (acquired)

141

407

2.50

21.17

1.4

1.6

5.02

6.15

u/l

1.51

122

340

Hard cardiovascular diseases

377

1289

1.75

21.12

1.5

1.4

7.13

5.44

u/l

1.31

318

1093

Other extrapyramidal and movement disorders in other diseases

129

516

2.52

21.08

1.4

1.5

5.26

6.39

u/l

1.60

107

429

Other diseases of pleura

204

864

2.08

20.76

1.8

1.5

7.83

6.07

u/l

0.80

178

715

Percutaneous Coronary Intervention

353

1226

1.77

20.74

1.5

1.4

7.02

5.72

u/l

1.10

309

1038

Haemorrhage from respiratory passages

146

557

2.37

20.64

1.4

6.33

5.94

u/l

0.22

123

467

Budesonide

206

3.47

20.63

1.5

1.2

5.72

5.97

u/l

0.11

178

Exclusions for E4_PCOS_BROAD

108

400

2.72

20.60

1.6

1.5

6.80

6.15

u/l

0.18

342

Bacterial pneumonia (organism specified)

203

893

2.07

20.57

1.7

1.5

6.50

6.11

u/l

0.27

164

748

Disorders of skin appendages

235

1210

1.95

20.44

1.5

5.88

5.78

u/l

0.05

193

1031

Major coronary heart disease event

370

1289

1.74

20.33

1.5

1.4

6.89

5.70

u/l

1.03

323

1091

Infections of the skin and subcutaneous tissue

271

1452

1.86

20.29

1.7

1.4

5.58

6.26

u/l

1.19

223

1239

Coronary revascularization (ANGIO or CABG)

351

1226

1.76

20.16

1.5

1.4

7.00

5.72

u/l

1.08

308

1038

Viral infections characterized by skin and mucous membrane lesions

386

1969

1.68

20.10

1.6

1.4

5.83

5.92

u/l

0.06

324

1651

Other bursopathies

172

3.69

20.06

1.6

1.5

7.03

6.00

u/l

0.17

145

Implicit bacterial Sepsis

185

775

2.12

20.01

1.6

1.5

8.19

5.72

u/l

0.92

155

650

Temporomandibular joint disorders, including avohilmo

222

1114

1.97

20.01

1.3

1.5

5.00

5.90

u/l

2.25

186

933

Disorders of parathyroid gland

108

401

2.68

20.00

1.4

1.6

4.86

6.35

u/l

2.15

331

Bacterial Sepsis

209

882

2.03

19.98

1.5

8.07

5.67

u/l

1.06

176

737

Diseases of arteries, arterioles and capillaries

287

1155

1.84

19.96

1.5

6.49

5.98

u/l

0.28

241

966

Selective serotonin reuptake inhibitors

418

1298

1.69

19.95

1.4

1.5

5.78

6.07

u/l

0.20

350

1087

Emergency coronary revascularization (for ACS)

371

1311

1.73

19.94

1.5

1.4

6.92

5.71

u/l

1.06

323

1104

Sulfasalazine

121

482

2.52

19.94

1.3

1.2

4.96

5.84

u/l

1.42

102

409

Neuralgia and neuritis, unspecified

5.79

19.79

1.5

5.80

6.30

u/l

0.32

All influenza

130

538

2.43

19.75

1.8

1.5

6.75

5.58

u/l

0.36

107

458

Benign neoplasms

434

1447

1.66

19.71

1.4

1.5

5.62

5.86

u/l

0.22

368

1227

Implicit bacterial Sepsis

201

850

2.05

19.71

1.5

7.94

5.72

u/l

0.88

168

710

Bacterial pneumonia, not elsewhere classified

179

742

2.13

19.55

1.7

1.5

6.68

5.99

u/l

0.51

144

628

Diaphragmatic hernia

174

820

2.13

19.43

1.5

5.61

6.18

u/l

0.56

138

691

Bacterial pneumoniae

187

792

2.09

19.38

1.7

1.4

6.63

5.95

u/l

0.53

151

669

Other specified/unspecified soft tissue disorders

6.36

19.30

1.4

1.3

4.92

5.74

u/l

0.80

Syncope and collapse

172

688

2.15

19.05

1.5

1.4

5.29

5.89

u/l

1.39

148

576

Seronegative rheumatoid arthritis

152

3.78

18.80

1.6

1.3

5.70

7.09

u/l

0.57

127

All kidney diseases

434

1841

1.61

18.67

1.6

1.4

6.54

5.66

u/l

0.85

356

1554

Factors influencing health status and contact with health services

126

243

2.61

18.61

1.4

8.51

6.43

u/l

0.65

107

205

Pain and other conditions associated with female genital organs and menstrual cycle

110

395

2.58

18.59

1.3

1.5

4.62

5.76

u/l

1.69

322

Hypothyroidism, strict autoimmune, 3 medication purchases required

367

1475

1.68

18.56

1.4

1.5

5.63

5.82

u/l

0.15

296

1235

Benzodiazepine use

440

1892

1.60

18.48

1.3

1.5

6.29

5.82

u/l

0.31

351

1604

Cutaneous lupus erythematosus

6.57

18.46

1.9

1.4

4.96

7.44

u/l

0.78

Subjective visual disturbances

134

582

2.32

18.32

1.3

1.5

4.74

6.43

u/l

2.91

107

492

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

270

1489

1.80

18.26

1.4

1.5

6.16

6.05

u/l

0.04

223

1250

Psoriatic and enteropathic arthropathies

174

3.53

18.25

1.2

1.3

4.94

6.29

u/l

0.72

144

Codes for special purposes

240

1300

1.85

17.92

1.4

1.5

5.71

5.93

u/l

0.23

201

1088

Paroxysmal tachycardia

107

350

2.57

17.71

1.4

1.3

5.71

5.70

u/l

0.00

299

Muscular dystrophy

22.64

17.62

1.8

1.2

8.76

8.67

u/l

0.01

Provisional assignment of new diseases of uncertain etiology

239

1300

1.84

17.62

1.4

1.5

5.71

5.93

u/l

0.24

201

1087

Covid-19 confirmed case

166

799

2.09

17.58

1.4

1.5

5.48

6.03

u/l

0.69

142

667

Diseases of salivary glands

165

794

2.09

17.51

1.6

1.5

5.64

6.03

u/l

0.40

142

672

Lateral epicondylitis

204

3.26

17.43

1.3

1.4

5.17

5.96

u/l

1.10

176

Ischemic heart diseases

356

1277

1.68

17.38

1.6

1.4

6.58

5.69

u/l

0.73

310

1079

Cystitis

361

1287

1.67

17.33

1.4

1.5

5.34

5.93

u/l

1.07

293

1066

Migraine without aura and triptan purchases

356

2.66

17.27

1.4

1.5

4.58

5.93

u/l

2.61

304

STROKE

244

898

1.85

17.12

1.4

6.44

5.62

u/l

0.39

202

760

Mycoses

371

1996

1.62

16.93

1.4

1.5

6.04

5.88

u/l

0.13

303

1683

Other shoulder lesions

123

3.93

16.78

1.4

4.99

6.18

u/l

1.23

104

Artrosis, including avohilmo

366

1214

1.65

16.60

1.4

1.5

6.26

u/l

0.00

318

1018

Abnormal serum enzyme levels

134

593

2.21

16.44

2.0

1.4

6.30

6.69

u/l

0.26

116

506

Mycoses

138

636

2.18

16.41

1.4

1.5

5.75

5.99

u/l

0.21

115

541

Coxarthrosis

181

593

2.02

16.29

1.3

1.5

5.29

6.79

u/l

2.02

158

489

Cerebrovascular diseases (FINNGEN)

138

439

2.23

16.21

1.5

1.3

7.26

5.58

u/l

0.49

114

373

Other enthesopathy of foot (+metatarsalgia)

140

3.67

16.19

1.1

1.5

4.59

5.77

u/l

2.01

117

Ganglion

322

2.68

16.17

1.3

5.43

5.92

u/l

0.24

277

Exposure to unspecified factor

426

1972

1.56

16.00

1.4

1.5

6.05

5.87

u/l

0.11

357

1654

Adhesive capsulitis of shoulder

236

2.98

15.99

1.3

1.4

5.47

6.25

u/l

0.51

199

Fibroblastic disorders

324

2.67

15.98

1.4

1.3

5.36

5.60

u/l

0.26

268

Nausea and vomiting

117

498

2.31

15.97

1.6

1.5

5.26

6.46

u/l

1.45

420

Allergic asthma (mode)

101

403

2.46

15.89

1.3

1.4

5.27

6.13

u/l

0.97

351

Chronic gastritis

122

543

2.26

15.81

1.5

5.18

5.87

u/l

1.44

101

455

Other (seronegative) rheumatoid arthritis, wide

101

414

2.46

15.80

1.9

1.5

5.99

6.28

u/l

0.20

352

Allergic asthma (mode), excluding more controls

101

404

2.46

15.80

1.3

1.4

5.27

6.07

u/l

0.88

352

Zoster [herpes zoster]

367

2.55

15.76

1.5

1.6

5.26

6.57

u/l

1.32

309

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

251

1436

1.75

15.71

1.3

1.5

6.14

6.05

u/l

0.03

209

1211

Other/unspecified enthesopathies of lower limb, excluding foot

4.37

15.67

1.1

1.7

4.63

6.01

u/l

1.53

Candidiasis

143

681

2.11

15.66

1.3

1.5

6.91

5.84

u/l

0.43

112

574

Trigger finger

218

3.05

15.64

1.1

1.4

4.91

6.34

u/l

1.23

183

Use of pramipexole

112

488

2.31

15.30

1.4

1.5

5.43

6.03

u/l

0.48

410

Tumor necrosis factor alpha inhibitors

373

2.51

15.27

1.2

1.5

5.07

6.49

u/l

1.55

320

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

247

1386

1.74

15.00

1.4

1.5

5.15

5.80

u/l

1.68

201

1160

Internal derangement of knee

141

676

2.08

14.96

1.2

1.5

5.48

7.05

u/l

1.87

112

565

Diseases of arteries, arterioles and capillaries (FINNGEN)

105

300

2.43

14.90

1.2

1.3

8.35

5.61

u/l

0.72

257

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

178

3.23

14.89

1.4

1.6

5.34

7.42

u/l

1.16

152

Postprocedural disorders of nervous system

145

3.49

14.68

1.4

5.06

6.18

u/l

0.83

120

Diseases of the ear and mastoid process

501

1684

1.50

14.63

1.5

1.4

5.94

5.95

u/l

0.01

415

1417

Functional dyspepsia

129

607

2.14

14.61

1.3

1.4

4.95

5.83

u/l

1.82

110

515

Symptoms and signs involving the urinary system

318

1491

1.63

14.60

1.5

1.4

6.26

6.04

u/l

0.10

259

1266

Parkinson's disease, strict definition, excluding more controls

115

3.75

14.57

1.2

1.4

5.72

6.31

u/l

0.18

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.40

14.53

1.5

1.4

5.21

6.35

u/l

0.67

Speech therapy

131

622

2.12

14.51

1.8

1.5

5.10

6.26

u/l

1.85

110

520

Respiratory insufficiency

4.20

14.51

1.4

10.15

7.78

u/l

0.23

Psoriatic arthropathies

151

3.40

14.49

1.2

1.6

4.99

6.18

u/l

1.08

127

Neuromuscular dysfunction of bladder

176

3.21

14.48

1.2

1.8

5.08

6.32

u/l

1.23

153

Oter anti-inflammatory and antirheumatic agents, non-steroids

177

2.72

14.44

1.3

1.5

5.71

6.53

u/l

0.54

145

Viral infections characterized by skin and mucous membrane lesions

191

1035

1.85

14.42

1.5

5.43

6.09

u/l

1.18

156

892

Renal tubulo-interstitial diseases

360

1705

1.58

14.37

1.5

1.4

7.29

5.54

u/l

1.34

294

1433

Cervicocranial syndrome

147

3.43

14.36

1.2

1.7

5.00

6.22

u/l

1.37

127

Other diseases of the respiratory system

378

2.45

14.36

1.5

7.74

6.08

u/l

0.47

316

Other respiratory disorders and diseases

378

2.45

14.36

1.5

7.74

6.08

u/l

0.47

316

Triptan medication for migraine, min. 3 purchases

261

1172

1.70

14.25

1.4

1.5

4.77

5.81

u/l

3.37

211

990

Other symptoms and signs involving cognitive functions and awareness

188

925

1.86

14.14

1.4

1.5

7.32

5.99

u/l

0.42

155

769

Other external causes of accidental injury

355

1110

1.61

14.14

1.5

1.4

5.91

5.77

u/l

0.12

304

926

Other and unspecified urticaria

104

455

2.30

14.11

1.5

5.24

6.15

u/l

0.94

382

Other and unspecified anaemias

172

864

1.90

14.08

1.4

1.5

6.50

6.10

u/l

0.16

133

724

Procreative management

162

694

1.95

13.99

1.4

1.6

5.70

6.07

u/l

0.40

135

588

Propionic acid derivatives

104

212

2.47

13.98

1.6

1.5

7.49

7.10

u/l

0.08

175

Dentofacial anomalies [including malocclusion]

308

1531

1.62

13.97

1.4

1.5

5.09

5.94

u/l

2.24

258

1298

Other/unspecified enthesopathies, not elsewhere classified

103

3.91

13.94

1.3

1.4

4.96

6.19

u/l

1.08

Other anaemias

173

873

1.89

13.86

1.4

1.5

6.47

6.08

u/l

0.16

134

730

Continuous positive airway pressure

264

2.60

13.81

1.2

1.4

5.35

5.78

u/l

0.44

225

Parkinson's disease, excluding more controls

127

3.50

13.80

1.2

1.3

5.82

6.27

u/l

0.14

Faecal incontinence

156

3.30

13.79

1.3

5.05

5.91

u/l

0.44

125

Hyperparathyroidism

351

2.47

13.77

1.2

1.6

4.87

6.19

u/l

2.10

288

Nonorganic sleeping disorders, excluding more controls

380

2.41

13.73

1.3

1.4

8.12

6.05

u/l

0.58

328

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

409

1755

1.52

13.62

1.4

1.5

5.56

5.91

u/l

0.55

338

1475

Metatarsalgia

128

3.54

13.61

1.2

1.5

4.63

5.83

u/l

1.81

109

Fenamates

142

3.03

13.40

1.2

1.6

5.08

6.38

u/l

0.98

118

Aplastic and other anaemias

182

925

1.84

13.38

1.4

1.5

6.38

6.08

u/l

0.13

141

774

Benign neoplasm of colon, rectum, anus and anal canal

254

1323

1.67

13.24

1.5

1.4

5.98

5.92

u/l

0.03

207

1116

Triptan medication for migraine, single purchase ok

337

1453

1.57

13.23

1.4

1.5

4.83

5.98

u/l

4.14

280

1239

Migraine, single triptan purchase ok & required. ICD-code if available is included

337

1453

1.57

13.23

1.4

1.5

4.83

5.98

u/l

4.14

280

1239

Atrial fibrillation and flutter with reimbursement

104

285

2.33

13.22

1.5

1.4

7.23

5.39

u/l

0.66

245

Endometriosis

155

458

1.99

13.12

1.3

1.4

4.76

5.80

u/l

1.74

128

370

Diverticular disease of intestine

284

1108

1.64

13.04

1.6

1.4

5.46

6.20

u/l

0.70

240

939

Zoster [herpes zoster]

206

1161

1.75

13.00

1.6

1.5

6.13

6.10

u/l

0.01

179

961

Papulosquamous disorders

176

964

1.83

12.94

1.3

1.5

5.38

6.16

u/l

1.45

153

819

Other symptoms and signs involving the digestive system and abdomen

324

2.48

12.93

1.9

1.4

5.27

6.83

u/l

0.97

273

Allergic conjunctivitis

253

1494

1.65

12.92

1.4

1.5

5.15

5.75

u/l

1.59

206

1252

Polyuria

104

474

2.21

12.84

1.6

1.5

5.32

6.29

u/l

0.77

403

Scoliosis

105

3.74

12.79

2.0

1.6

4.37

6.07

u/l

2.08

External causes of morbidity and mortality

282

856

1.65

12.70

1.5

6.44

5.85

u/l

0.35

244

716

Accidents

347

1110

1.57

12.64

1.5

1.4

6.33

5.77

u/l

0.40

295

926

Use of hypnotics and sedatives

445

1733

1.48

12.64

1.5

1.4

6.13

5.90

u/l

0.15

367

1469

275

2.60

12.60

1.7

1.5

5.32

6.10

u/l

0.78

230

Other disorders of the musculoskeletal system and connective tissue

311

2.49

12.54

1.8

1.5

5.43

6.68

u/l

0.87

264

Acetic acid derivatives and related substances

200

2.45

12.54

1.4

1.5

7.27

7.18

u/l

0.02

164

Other and unspecified drugs and medicaments

171

3.07

12.52

1.3

1.6

5.24

7.35

u/l

1.13

146

Hypo-osmolality and hyponatraemia

292

2.53

12.48

1.6

1.5

4.85

5.80

u/l

1.42

237

Restless leg syndrome

283

2.56

12.42

1.5

5.30

6.64

u/l

1.15

244

Atopic dermatitis

238

1170

1.67

12.33

1.4

1.5

5.21

5.96

u/l

1.59

201

989

KRA_PSY_EATING, excluding more controls

122

3.45

12.23

1.4

1.5

5.94

5.97

u/l

0.01

101

Asthma and allergy

192

2.89

12.19

1.4

5.29

6.03

u/l

0.60

168

Other and unspecified effects of external causes

131

665

1.98

12.18

1.3

1.5

5.62

6.03

u/l

0.38

110

566

Meniscus derangement

190

717

1.79

12.10

1.2

1.5

5.30

6.88

u/l

1.99

158

597

Adverse effects, not elsewhere classified

100

460

2.19

12.10

1.3

1.5

4.98

6.22

u/l

1.57

390

Coagulation defects, purpura and other haemorrhagic conditions

435

2.22

12.06

1.8

1.5

5.34

6.24

u/l

0.85

367

Diseases of pulp and periapical tissues, including avohilmo

433

1522

1.48

12.04

1.7

1.4

6.02

6.00

u/l

0.01

376

1266

Heart failure and antihypertensive medication

286

2.27

12.03

2.0

1.3

7.07

5.37

u/l

0.55

246

Disorders of mineral metabolism

144

3.22

12.03

1.1

1.4

5.14

5.97

u/l

0.69

125

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

181

630

1.82

11.99

1.6

1.3

5.98

5.45

u/l

0.28

156

542

Asthma and allergy, excluding more controls

194

2.86

11.97

1.4

5.29

5.97

u/l

0.54

170

Neoplasms

324

1100

1.56

11.83

1.4

1.5

5.85

5.91

u/l

0.04

276

928

Injuries to the knee and lower leg

482

1866

1.44

11.81

1.6

1.4

5.43

5.86

u/l

1.00

416

1549

Primary hyperparathyroidism

222

2.73

11.70

1.2

1.6

4.81

6.41

u/l

1.18

184

Congenital malformations and deformations of the musculoskeletal system

177

2.95

11.69

1.5

1.6

5.63

6.44

u/l

0.44

148

Renal failure

172

852

1.79

11.55

1.5

8.79

5.96

u/l

0.92

132

711

Congenital malformations and deformations of the musculoskeletal system

234

2.65

11.49

1.5

1.6

5.66

6.24

u/l

0.38

195

Diseases of liver

150

813

1.85

11.48

1.8

1.4

7.85

5.94

u/l

0.97

133

689

Behavioural syndromes associated with physiological disturbances and physical factors

379

1817

1.48

11.45

1.4

1.5

6.21

5.74

u/l

0.42

322

1528

Inflammatory diseases of female pelvic organs

254

1157

1.62

11.42

1.4

1.5

4.99

5.38

u/l

1.05

213

945

Other hammer toe(s) (acquired)

232

2.60

11.39

1.6

1.7

5.40

7.00

u/l

1.20

187

Hernia

380

1724

1.48

11.31

1.5

5.53

6.04

u/l

0.88

327

1455

Noninfective enteritis and colitis

196

1153

1.70

11.28

1.7

1.4

5.96

5.91

u/l

0.03

162

982

Implicit fungal Sepsis

4.37

11.25

1.1

1.4

5.60

5.63

u/l

0.01

Fall on same level

469

1795

1.43

11.18

1.5

1.4

6.49

5.78

u/l

0.59

398

1505

Fungal Sepsis

4.20

11.09

1.1

1.5

5.57

5.64

u/l

0.02

Gingivitis and periodontal diseases

414

1462

1.46

11.08

1.6

1.4

5.73

5.85

u/l

0.13

361

1217

Ankylosing spondylitis

126

3.28

11.06

1.6

1.7

4.56

6.50

u/l

2.44

111

Dental caries, including avohilmo

295

960

1.58

11.06

1.6

1.5

6.02

6.23

u/l

0.13

258

788

Hyperkinetic disorders, excluding more controls

175

2.86

11.04

1.5

1.7

5.13

6.12

u/l

0.75

147

Other diseases of hard tissues of teeth

228

704

1.68

11.02

1.5

1.4

6.18

6.33

u/l

0.08

196

575

Other and unspecified rosacea

179

2.88

11.00

1.6

1.7

4.86

5.92

u/l

1.33

156

Rosacea

247

2.57

10.98

1.5

1.7

4.86

6.17

u/l

1.70

211

Paracetamol or NSAID medication

104

2.91

10.98

1.5

1.4

8.30

7.26

u/l

0.21

Personality disorders, excluding more controls

108

532

2.04

10.96

1.2

1.4

6.53

5.82

u/l

0.22

449

Viral pneumonia

230

2.62

10.93

1.5

5.22

5.92

u/l

0.62

196

Other inflammation of eyelid

284

2.45

10.86

1.4

1.5

5.38

7.02

u/l

1.26

242

Gout

373

2.18

10.85

1.4

1.5

5.61

6.80

u/l

1.00

302

Reactive arthropathies, FINNGEN

3.74

10.84

1.4

1.3

5.77

7.86

u/l

0.55

Psoriasis

129

680

1.91

10.80

1.2

1.5

5.44

6.24

u/l

1.02

114

577

Persons encountering health services in other circumstances

161

906

1.77

10.72

1.7

1.5

8.26

6.04

u/l

0.67

138

760

Etanercept

139

3.13

10.72

1.2

1.6

5.08

6.56

u/l

1.12

116

Anti-inflammatory and antirheumatic products, non-steroids

212

2.26

10.65

1.7

1.5

7.89

7.10

u/l

0.16

175

Impingement syndrome of shoulder

362

2.25

10.56

1.3

5.33

5.97

u/l

0.62

312

Atrial fibrillation and flutter

122

401

1.98

10.52

1.5

1.3

7.02

5.68

u/l

0.51

105

346

Hypokalaemia

206

2.69

10.50

1.2

1.7

7.90

5.43

u/l

0.87

173

Benign neoplasm: Colon

209

1221

1.64

10.37

1.5

6.25

6.00

u/l

0.11

168

1030

Other gastritis (incl. Duodenitis)

463

2.08

10.35

1.4

1.5

7.01

5.96

u/l

0.29

398

Postprocedural musculoskeletal disorders, not elsewhere classified

132

3.14

10.30

1.6

1.5

4.47

6.94

u/l

1.21

110

Injury, poisoning and certain other consequences of external causes

220

664

1.66

10.26

1.6

1.5

6.97

5.82

u/l

0.61

192

551

Other diseases of blood and blood-forming organs, wide

103

513

2.02

10.20

1.9

1.5

6.82

5.96

u/l

0.63

432

Other nutritional deficiencies

273

1682

1.53

10.16

1.6

1.4

6.04

5.88

u/l

0.10

237

1409

Other and unspecified visual disturbances

199

2.68

10.10

1.5

8.58

7.29

u/l

0.13

168

Other acute lower respiratory infections

207

1213

1.63

10.08

1.7

1.4

5.42

6.18

u/l

1.34

184

1023

Disorders of vestibular function (Vertigo)

187

1104

1.67

10.07

1.3

1.5

6.07

5.99

u/l

0.04

153

928

Other disorders of patella

295

2.35

10.00

1.5

4.96

6.52

u/l

1.57

256

Angina pectoris

213

869

1.64

9.95

1.4

5.91

5.60

u/l

0.38

182

724

Conjunctivitis (acute, non atopic)

123

654

1.88

9.95

1.5

1.6

5.15

6.08

u/l

1.65

102

556

All chronic kidney diseases

208

1045

1.63

9.93

1.5

1.4

7.35

5.77

u/l

0.66

165

891

Pain associated with micturition

236

2.52

9.90

1.2

1.6

4.73

6.90

u/l

1.93

201

Genitourinary diseases

234

726

1.62

9.85

1.5

7.37

5.89

u/l

0.96

209

623

Other noninfective gastroenteritis and colitis

107

547

1.96

9.83

1.8

1.4

5.45

6.00

u/l

0.58

458

Panic disorder

310

2.30

9.83

1.5

1.4

4.92

6.08

u/l

1.54

259

Arthropathic psoriasis

243

2.49

9.82

1.2

1.6

5.45

6.94

u/l

0.95

203

Diagnoses used for exclusion with ILD

109

563

1.94

9.74

1.7

1.5

5.33

6.29

u/l

1.37

479

Other coagulation defects

142

2.98

9.72

2.1

1.5

5.00

6.21

u/l

1.00

119

Ischaemic heart disease, wide definition

298

1225

1.51

9.71

1.5

1.4

7.29

5.67

u/l

1.22

258

1037

Other sleep disorders

192

2.67

9.68

1.2

1.5

6.58

6.70

u/l

0.03

167

Lesion of ulnar nerve

275

2.38

9.67

1.8

1.4

5.01

6.66

u/l

1.47

237

Bleeding

318

1532

1.48

9.63

1.4

7.47

5.79

u/l

0.97

266

1299

Disorders of calcium metabolism

102

3.36

9.58

1.1

1.4

5.31

6.49

u/l

0.74

Adalimumab

217

2.55

9.52

1.1

1.6

5.05

6.73

u/l

1.73

183

Other skin changes

379

2.15

9.50

1.6

5.31

5.99

u/l

0.77

315

Explicit Sepsis

166

916

1.70

9.43

1.3

1.4

7.51

5.58

u/l

1.18

131

764

Localized swelling, mass and lump of skin and subcutaneous tissue

127

700

1.82

9.31

1.5

5.80

6.12

u/l

0.30

110

593

Pruritus

196

2.62

9.31

1.3

1.5

8.27

6.76

u/l

0.20

166

Nutritional anaemias

188

1112

1.63

9.30

1.5

1.4

5.67

5.96

u/l

0.15

158

921

Other degenerative diseases of the nervous system

274

2.19

9.29

1.3

1.4

5.34

6.06

u/l

0.83

224

Other disorders of eye and adnexa

318

2.25

9.29

1.4

1.5

5.60

6.60

u/l

0.72

271

Synovial cyst of popliteal space [Baker]

3.65

9.26

1.9

1.4

10.68

6.29

u/l

0.34

Dental operations

230

741

1.60

9.26

1.6

1.4

6.20

6.57

u/l

0.20

202

597

Achilles tendinitis

157

2.82

9.25

1.7

1.6

5.45

6.09

u/l

0.58

136

Postprocedural endocrine and metabolic disorders, not elsewhere classified

257

2.39

9.19

1.4

1.5

5.48

5.46

u/l

0.01

217

Other and unspecified coagulation defects

100

3.34

9.18

1.2

1.5

5.06

6.43

u/l

0.83

Sleep disorders

352

1777

1.43

9.12

1.4

1.5

6.26

5.73

u/l

0.46

299

1492

Coronary atherosclerosis

238

967

1.56

9.08

1.6

1.4

7.64

5.85

u/l

1.02

206

811

All influenza (not pneumonia)

302

2.26

9.07

1.8

1.6

5.15

5.82

u/l

0.67

260

Other viral diseases

162

958

1.68

9.04

1.6

1.5

5.50

5.83

u/l

0.46

135

829

Hypoparathyroidism

3.88

8.98

1.9

1.4

4.74

7.20

u/l

1.35

Cerebrovascular diseases

274

1284

1.50

8.98

1.4

1.5

7.90

5.84

u/l

0.96

219

1085

Suggestive for eosinophilic asthma

177

2.68

8.95

1.5

5.65

7.57

u/l

1.03

155

Other diseases of liver

422

2.05

8.93

1.8

1.5

5.55

6.19

u/l

0.51

356

Other metabolic disorders

273

2.32

8.92

1.4

1.5

5.46

5.41

u/l

0.03

227

Diseases of oral cavity, salivary glands and jaws

219

705

1.60

8.92

1.6

1.4

6.27

6.33

u/l

0.03

195

575

Diseases of pulp and periapical tissues and dental caries

254

844

1.54

8.88

1.6

1.5

6.20

6.35

u/l

0.08

226

686

Reactive arthropathies

123

3.03

8.84

1.3

1.6

5.90

6.47

u/l

0.31

106

Plantar fascial fibromatosis

134

2.93

8.79

1.2

1.4

4.95

5.90

u/l

1.43

114

Congenital malformations, deformations and chromosomal abnormalities

259

1595

1.50

8.77

1.5

5.09

5.98

u/l

2.47

214

1354

Other disorders of white blood cells

3.30

8.76

2.2

1.4

6.11

8.06

u/l

0.51

Disorders of sclera, cornea, iris and ciliary body

219

1419

1.55

8.69

1.6

1.5

6.01

6.09

u/l

0.03

187

1212

Venous thromboembolism

202

1240

1.58

8.68

1.7

1.4

6.08

6.09

u/l

0.00

178

1035

Collagenous colitis

180

2.63

8.67

1.7

1.4

5.75

7.20

u/l

0.66

152

Use of levodopa decarboxylase inhibitor

240

2.39

8.62

1.5

1.4

5.64

6.73

u/l

0.44

202

Nonorganic sleeping disorders

462

1.98

8.61

1.3

1.5

8.12

5.84

u/l

0.67

396

Diplopia

259

2.33

8.59

1.4

1.5

4.93

6.81

u/l

1.69

222

Diabetic neuropathy

192

2.56

8.53

1.6

1.7

5.27

7.07

u/l

1.15

172

Excessive, frequent and irregular menstruation

154

489

1.73

8.53

1.5

1.4

4.89

5.75

u/l

1.21

124

394

Falls/tendency to fall

430

1559

1.38

8.53

1.5

1.4

6.07

5.77

u/l

0.28

374

1305

Bipolar affective disorders

423

2.02

8.51

1.3

1.5

6.17

6.39

u/l

0.06

370

Caries of dentine, including avohilmo

304

1057

1.47

8.50

1.6

1.5

6.04

6.14

u/l

0.07

265

869

Dermatophytosis

267

2.30

8.46

1.5

1.6

5.69

6.74

u/l

0.62

229

Missing teeth due to accident, extraction or parodontitis

225

1389

1.53

8.42

1.4

1.5

5.27

6.05

u/l

1.85

182

1180

Injuries to the wrist and hand

392

1961

1.39

8.40

1.4

1.5

5.90

5.91

u/l

0.01

331

1646

Other disorders of nervous system

127

2.94

8.39

1.3

1.5

5.19

8.23

u/l

1.29

107

Ovarian cyst

142

469

1.75

8.31

1.5

1.4

4.64

5.79

u/l

2.08

119

377

Dialysis, with operation codes

258

2.30

8.22

1.7

1.4

5.33

6.14

u/l

0.66

221

Atypical facial pain

3.29

8.21

1.1

1.3

5.06

6.13

u/l

0.81

Myasthenia gravis

6.96

8.12

1.0

1.3

5.33

6.88

u/l

0.39

5-aminosalicylic acid

357

2.08

8.08

1.4

1.2

5.50

5.87

u/l

0.31

311

Otalgia

158

2.68

8.05

1.3

1.5

5.15

6.98

u/l

0.93

134

Other disorders of eyelid

158

918

1.64

8.05

1.4

5.07

6.21

u/l

2.72

125

766

Heart failure,strict

190

846

1.59

8.04

1.8

1.4

7.87

5.99

u/l

0.77

157

700

Septicaemia

153

866

1.66

8.04

1.4

1.5

7.83

6.01

u/l

0.93

120

719

Other viral diseases

125

716

1.75

8.03

1.7

1.5

5.59

6.00

u/l

0.48

105

621

Other/unspecified rheumatoid arthritis

236

2.34

8.01

2.2

1.5

5.58

6.63

u/l

0.63

201

Disorder of lipoprotein metabolism, unspecified

230

2.36

7.99

1.6

1.4

9.93

5.67

u/l

0.73

189

Sarcoidosis

300

2.18

7.97

1.6

1.5

5.54

6.66

u/l

0.88

257

Endometriosis of pelvic peritoneum

335

2.09

7.95

1.3

1.5

4.61

5.87

u/l

1.63

279

Candidiasis

288

2.20

7.91

1.3

1.6

5.45

6.61

u/l

0.84

246

Generalized anxiety disorder

334

2.11

7.88

1.2

1.4

4.78

6.47

u/l

1.73

278

Diseases of inner ear

207

1310

1.53

7.87

1.3

1.5

6.04

5.90

u/l

0.10

170

1106

Erysipelas

266

1389

1.46

7.87

1.4

6.39

5.73

u/l

0.45

232

1178

Other infectious diseases

166

2.61

7.84

1.5

7.74

7.33

u/l

0.07

143

Insomnia

338

1759

1.40

7.83

1.4

1.5

6.16

5.70

u/l

0.38

285

1480

Hyperkalaemia

3.49

7.82

1.5

1.4

5.36

5.93

u/l

0.21

Gonarthrosis,primary

334

1461

1.41

7.79

1.4

5.75

6.12

u/l

0.42

282

1221

Injuries to the thorax

171

1075

1.59

7.78

1.5

1.4

7.03

6.09

u/l

0.31

151

910

Unspecified privation

221

2.37

7.75

2.4

1.4

5.65

7.19

u/l

0.98

191

Hyperlipidaemia, other/unspecified

134

728

1.70

7.74

1.6

1.5

5.42

5.86

u/l

0.38

111

605

Diseases of the digestive system

168

1051

1.59

7.66

1.8

1.4

5.96

6.05

u/l

0.03

138

883

Ocular pain

174

2.55

7.66

1.2

1.6

5.54

6.88

u/l

0.65

150

Cutaneous abscess, furuncle and carbuncle

109

611

1.79

7.65

1.7

1.4

5.64

6.22

u/l

0.61

524

Retention of urine

121

569

1.75

7.63

1.5

6.44

6.60

u/l

0.07

478

Nephropathy related operations

254

2.26

7.63

1.6

1.5

5.65

6.84

u/l

0.65

218

Menorrhagia

136

438

1.73

7.58

1.5

1.4

4.85

5.80

u/l

1.23

113

356

Hemiplegia

3.18

7.54

1.2

1.5

4.72

6.39

u/l

1.12

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

103

568

1.81

7.53

1.3

1.5

6.75

5.78

u/l

0.41

481

Traumatic subdural haemorrhage

129

2.76

7.51

1.8

1.3

11.69

6.17

u/l

0.43

107

Benign neoplasm of other and ill-defined parts of digestive system

388

1.99

7.51

1.4

1.6

5.62

6.30

u/l

0.48

330

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

118

681

1.74

7.51

1.4

1.5

4.94

5.84

u/l

1.72

101

586

Acute bronchitis

154

935

1.62

7.47

1.7

1.5

5.53

6.12

u/l

0.81

136

788

Hernia of abdominal wall, postoperative

308

2.12

7.47

1.5

1.3

4.97

5.65

u/l

0.79

263

Other septicaemia

134

770

1.68

7.46

1.4

1.5

8.11

6.08

u/l

0.90

103

636

Other symptoms and signs involving the circulatory and respiratory systems

103

3.03

7.46

1.6

1.4

6.99

7.66

u/l

0.10

Injuries to the abdomen, lower back, lumbar spine and pelvis

147

891

1.64

7.46

1.6

1.5

6.87

6.01

u/l

0.24

122

748

Urethritis and urethral syndrome

4.46

7.45

2.1

1.4

5.28

5.65

u/l

0.29

Nail disorders

165

2.56

7.42

1.6

1.5

5.38

6.61

u/l

0.83

141

Disorders of ocular muscles, binocular movement, accommodation and refraction

187

1204

1.54

7.42

1.4

1.5

5.04

5.96

u/l

2.73

147

1033

Algoneurodystrophy

3.47

7.41

1.3

5.55

6.59

u/l

0.40

Exclusions for E4_PCOS_CONSORTIUM

288

1260

1.43

7.41

1.3

1.5

5.96

5.66

u/l

0.26

243

1042

Benign neoplasm: Stomach

183

2.48

7.40

1.3

1.6

6.07

6.61

u/l

0.18

155

Acute renal failure

425

1.94

7.38

1.6

1.4

7.78

6.10

u/l

0.42

361

Unspecified/other endometriosis

174

2.49

7.15

1.3

1.5

4.70

5.67

u/l

1.18

148

Disorders of lens

251

1074

1.46

7.15

1.6

1.4

6.16

5.85

u/l

0.21

217

901

Persistent mood disorders

423

1.92

7.14

1.8

1.4

5.44

6.13

u/l

0.60

359

Chronic kidney disease

103

570

1.78

7.08

1.5

8.84

6.12

u/l

0.48

470

Deviated nasal septum

124

738

1.68

7.05

1.4

7.50

6.50

u/l

0.22

100

640

Iron deficiency anaemia

156

970

1.59

7.04

1.6

1.4

5.96

5.92

u/l

0.02

129

805

Disturbance of activity and attention

221

2.27

6.95

1.6

1.5

5.32

6.00

u/l

0.43

187

Enterocolitis due to Clostridium difficile

195

2.37

6.93

1.5

7.09

7.42

u/l

0.07

166

Disorders of choroid and retina

296

1502

1.40

6.92

1.6

1.4

5.81

5.93

u/l

0.07

245

1270

Other bacterial intestinal infections

499

1.83

6.92

1.5

6.07

6.40

u/l

0.14

417

Psoriatic arthropathies, ICD10

233

2.25

6.91

1.2

1.6

4.97

7.09

u/l

1.75

199

Other and unspecified mononeuropathies, also in other diseases

4.01

6.91

1.2

1.3

4.57

6.58

u/l

1.01

Other diseases of lip and oral mucosa

157

998

1.58

6.90

1.3

1.5

5.15

6.03

u/l

1.85

129

857

Other bacterial intestinal infections

366

1.98

6.88

1.6

6.30

6.50

u/l

0.07

312

Statin medication

276

1088

1.43

6.86

1.5

1.4

6.28

5.68

u/l

0.40

238

917

Herpesviral [herpes simplex] infections

103

588

1.76

6.85

1.4

1.5

5.10

6.04

u/l

1.35

500

Injuries to the ankle and foot

275

1737

1.41

6.84

1.4

1.5

5.76

5.88

u/l

0.10

247

1459

Early onset COPD, excluding more controls

326

2.03

6.82

1.4

5.56

6.62

u/l

1.03

288

Specific personality disorders

101

575

1.76

6.79

1.2

1.5

6.78

6.09

u/l

0.19

491

Congenital malformations, deformations and chromosomal abnormalities

229

1504

1.45

6.78

1.5

5.04

5.98

u/l

2.48

189

1281

Female genital prolapse

116

377

1.74

6.76

1.3

1.4

5.11

5.88

u/l

0.75

310

Liquid cancers, helper endpoint

143

776

1.61

6.74

1.4

7.66

5.95

u/l

0.71

115

657

Eating disorder

173

2.44

6.72

1.4

5.94

5.83

u/l

0.05

142

Childhood asthma (age<16), excluding more controls

138

2.46

6.71

1.6

1.5

4.94

5.70

u/l

0.58

115

Other and unspecified tonsillitis

127

645

1.66

6.69

1.6

1.5

5.20

6.55

u/l

1.91

108

565

Atopic dermatitis, strict definition with reimbursement

112

636

1.70

6.67

1.6

1.4

5.53

5.99

u/l

0.48

100

540

Ulcer of lower limb, not elsewhere classified

263

2.14

6.64

2.0

1.4

5.27

6.17

u/l

1.08

221

Trigeminal neuralgia

105

2.88

6.63

1.8

1.4

5.30

6.53

u/l

0.76

Volume depletion

133

2.64

6.63

1.7

1.4

5.33

6.23

u/l

0.65

113

Coeliac disease

257

2.15

6.61

2.6

1.5

5.31

5.94

u/l

0.64

228

Thyroiditis

145

2.57

6.61

1.3

1.5

4.57

5.67

u/l

1.39

124

Other cataract

162

786

1.56

6.59

1.7

1.5

6.43

6.19

u/l

0.10

137

647

Purpura and other haemorrhagic conditions

271

2.11

6.56

1.5

1.6

5.60

6.81

u/l

0.79

234

Other and unspecified iron deficiency

124

754

1.65

6.54

1.6

1.4

5.10

5.84

u/l

1.40

106

624

Exposure to other specified factors

287

1903

1.39

6.54

1.5

5.38

6.05

u/l

1.71

247

1604

Childhood asthma (age<16)

140

2.43

6.53

1.6

1.5

4.94

5.68

u/l

0.57

117

Abnormal results of function studies

176

2.40

6.52

1.9

1.5

5.64

7.21

u/l

1.11

155

Hyperkinetic disorders

240

2.17

6.51

1.5

5.17

6.02

u/l

0.63

202

Cellulitis

502

1.80

6.50

1.6

1.5

5.29

6.36

u/l

1.47

437

Bacterial intestinal infections, IBD co-morbidities

374

1.93

6.49

1.6

1.5

6.39

6.31

u/l

0.03

320

Major coronary heart disease event excluding revascularizations

204

916

1.49

6.46

1.6

1.4

8.05

5.59

u/l

1.46

177

765

Disorders of gallbladder, biliary tract and pancreas

372

1754

1.34

6.43

1.5

1.4

5.26

6.12

u/l

2.39

313

1469

Insulin, combination of fast acting with intermediate-acting or long-acting

220

1390

1.45

6.42

1.5

1.4

7.43

6.04

u/l

0.70

180

1179

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

135

844

1.60

6.40

1.6

1.4

5.25

5.90

u/l

0.81

111

722

Seropositive rheumatoid arthritis, wide

106

623

1.71

6.39

1.8

1.5

5.28

6.11

u/l

1.13

520

Pulmonary heart disease, diseases of pulmonary circulation

113

676

1.68

6.37

1.8

1.5

6.09

6.24

u/l

0.06

567

Vasomotor and allergic rhinitis

142

883

1.58

6.35

1.6

1.5

4.84

6.03

u/l

3.13

118

764

Fracture of rib(s), sternum and thoracic spine

111

663

1.68

6.31

1.5

7.25

6.09

u/l

0.26

564

Special screening examination for infectious and parasitic diseases

304

1.89

6.30

1.2

1.4

6.80

6.12

u/l

0.18

264

Convulsions, not elsewhere classified

373

1.91

6.29

1.6

1.4

9.16

6.29

u/l

0.44

320

Disorders of orbit

3.02

6.24

1.8

1.4

5.28

6.89

u/l

0.96

Chronic diseases of tonsils and adenoids

293

1342

1.38

6.21

1.5

1.4

5.44

5.87

u/l

0.58

257

1147

Cardiomyopathy, other and unspecified

150

2.48

6.18

1.6

1.4

6.13

6.44

u/l

0.14

123

Obesity and other hyperalimentation

242

1658

1.41

6.12

1.6

1.4

6.28

5.84

u/l

0.28

211

1389

Disease of hard tissues of teeth, NOS

198

697

1.49

6.05

1.6

1.4

5.75

6.34

u/l

0.53

174

569

Disorders of adult personality and behaviour

118

725

1.63

6.04

1.2

1.5

6.39

6.00

u/l

0.12

621

Acute tubulo-interstitial nephritis

222

1343

1.43

6.00

1.4

1.5

6.18

5.60

u/l

0.54

183

1126

Superficial injury of lower leg

570

1.71

5.89

1.9

1.5

5.27

6.20

u/l

1.23

479

Transient ischemic attack

180

984

1.48

5.87

1.3

1.5

6.10

6.16

u/l

0.02

149

818

Gout, FINNGEN

532

1.73

5.86

1.4

1.5

5.61

6.95

u/l

1.38

440

Paraplegia, diplegia of upper limbs

3.84

5.83

1.3

5.49

6.55

u/l

0.38

Adenomyosis (Endometriosis of uterus)

284

2.02

5.83

1.2

1.4

5.24

6.21

u/l

0.67

237

Vasculitis limited to skin, not elsewhere classified

3.83

5.83

1.4

5.24

7.93

u/l

0.86

Amenorrhoea

113

2.67

5.82

1.5

1.8

6.18

6.20

u/l

0.01

Pneumocystosis

4.96

5.77

1.3

1.2

5.74

7.07

u/l

0.37

132

771

1.57

5.75

1.6

1.5

5.29

6.34

u/l

1.73

108

633

Obesity

239

1656

1.39

5.75

1.6

1.4

6.31

5.84

u/l

0.30

208

1388

Pneumonia due to other infectious organisms, not elsewhere classified

3.49

5.74

1.2

1.7

6.49

6.30

u/l

0.04

Other abnormal findings of blood chemistry

2.99

5.69

2.2

1.5

6.81

6.75

u/l

0.01

Spontaneous rupture of synovium and tendon

103

2.73

5.68

1.9

1.5

9.64

6.19

u/l

0.59

Viral warts

207

2.19

5.68

1.6

1.5

6.27

7.46

u/l

0.49

177

Other disorders of ear

343

1696

1.33

5.65

1.5

1.4

5.72

6.06

u/l

0.30

284

1438

Abnormal findings on diagnostic imaging of other body structures

295

1.98

5.62

1.2

1.5

5.76

6.07

u/l

0.15

254

Other psoriatic arthropathies

228

2.12

5.60

1.2

1.6

4.95

6.93

u/l

1.59

195

Misadventures to patients during surgical and medical care

296

1.97

5.57

1.3

1.7

6.41

6.59

u/l

0.08

256

Strabismus

105

639

1.64

5.56

1.3

1.5

5.07

5.88

u/l

1.28

546

DVT of lower extremities and pulmonary embolism

145

950

1.52

5.56

1.8

1.4

5.88

6.05

u/l

0.10

127

788

Atherosclerosis, excluding cerebral and coronary sclerosis

126

631

1.58

5.55

1.5

7.63

6.49

u/l

0.29

102

517

Injuries to the head

412

1964

1.29

5.54

1.6

1.4

6.80

5.71

u/l

0.92

352

1640

Chronic pancreatitis

257

2.03

5.47

1.3

1.4

5.38

7.05

u/l

1.22

218

Protozoal diseases

3.27

5.46

1.4

1.6

5.74

6.17

u/l

0.15

Type 2 diabetes, wide definition

295

1402

1.35

5.45

1.5

1.4

6.31

5.73

u/l

0.42

246

1184

Pulmonary embolism

103

629

1.64

5.44

1.8

1.5

6.20

6.30

u/l

0.04

527

Insulin medication

220

1321

1.40

5.41

1.5

1.4

7.43

6.01

u/l

0.72

180

1123

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

385

1.78

5.40

1.5

1.6

5.40

5.95

u/l

0.50

325

Post-traumatic stress disorder

154

2.35

5.39

1.4

4.81

6.10

u/l

1.32

127

Acute pancreatitis

421

1.79

5.38

1.6

1.5

5.19

6.65

u/l

1.78

357

Erysipelas

190

1172

1.44

5.37

1.4

6.70

5.85

u/l

0.43

169

989

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

145

958

1.51

5.35

1.4

1.5

5.70

5.65

u/l

0.03

127

810

Irregular menses

182

992

1.45

5.35

1.4

5.07

5.39

u/l

0.59

142

829

Pulmonary heart disease

103

632

1.63

5.34

1.8

1.5

6.20

6.29

u/l

0.04

529

Infective dermatitis

219

2.11

5.34

1.2

1.6

4.73

7.11

u/l

1.91

186

Inflammatory disease of uterus

315

1.91

5.32

1.2

1.5

4.91

5.37

u/l

0.55

263

Interstitial myositis

+∞

5.32

4.2

0.0

7.20

—

u/l

—

Overexertion and strenuous or repetitive movements

213

2.12

5.31

1.6

1.5

5.71

7.49

u/l

0.98

182

Other/unspecified synovitis and tenosynovitis

149

2.36

5.30

1.4

1.5

5.17

6.23

u/l

1.31

127

Dermatophytosis

222

1598

1.39

5.30

1.5

6.12

6.07

u/l

0.02

181

1364

Other/unspecified seropositive rheumatoid arthritis

101

619

1.64

5.28

1.7

1.5

5.31

6.12

u/l

1.07

517

Ménière disease

181

2.22

5.28

1.2

1.6

5.11

7.31

u/l

1.28

156

Sequelae of external causes of morbidity and mortality

590

1.65

5.23

1.8

1.5

5.34

6.27

u/l

1.16

496

Phobic anxiety disorders

268

1.98

5.22

1.5

1.4

9.67

6.70

u/l

0.27

219

Artificial joint operation, meniscal resection

327

1614

1.32

5.18

1.4

5.28

6.20

u/l

2.29

279

1358

Fracture of lumbar spine and pelvis

433

1.76

5.17

1.7

1.5

4.77

6.53

u/l

2.52

357

Iridocyclitis

539

1.68

5.16

1.3

1.5

7.25

6.14

u/l

0.21

459

Non-rheumatic valve diseases

158

770

1.48

5.12

1.7

1.4

7.14

5.94

u/l

0.44

128

648

Nail dystrophy

8.65

5.11

1.0

1.3

6.08

8.66

u/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

100

617

1.63

5.11

1.7

1.5

5.31

6.12

u/l

1.07

516

All-cause Heart Failure

190

940

1.43

5.07

1.7

1.5

7.85

5.95

u/l

0.78

157

785

Mouth breathing

150

1014

1.48

5.07

1.5

6.65

6.16

u/l

0.13

127

876

Heart failure, strict

194

963

1.42

5.06

1.7

1.5

7.79

5.96

u/l

0.76

160

803

Actinic keratosis

118

701

1.56

5.05

1.7

1.5

5.29

6.34

u/l

1.56

571

Palmar fascial fibromatosis [Dupuytren]

191

2.15

5.04

1.7

1.3

5.54

5.67

u/l

0.07

160

Other menopausal disorders

107

370

1.63

5.04

1.4

4.56

5.88

u/l

1.77

304

Speech disturbances, not elsewhere classified

153

2.30

5.02

1.1

1.4

4.45

8.03

u/l

2.15

130

Psoriasis vulgaris

431

1.75

5.00

1.3

1.5

5.69

6.39

u/l

0.52

368

Acute pancreatitis (for exclusion)

431

1.75

5.00

1.6

1.5

5.19

6.58

u/l

1.72

368

Polycystic ovarian syndrome, consortium definition

262

1146

1.36

5.00

1.5

4.94

5.40

u/l

1.22

205

950

Valvular heart disease excluding rheumatic fever

158

775

1.47

4.99

1.7

1.4

7.03

5.94

u/l

0.39

127

652

Dislocation, sprain and strain of joints and ligaments at neck level

351

1.83

4.99

1.4

1.5

5.69

6.52

u/l

0.54

301

Dermatographic urticaria

135

2.39

4.97

1.2

1.5

5.09

6.04

u/l

0.51

114

Eating disorders

206

2.09

4.92

1.3

1.5

5.91

5.66

u/l

0.13

169

Heart failure and coronary heart disease

130

603

1.53

4.89

1.7

1.4

8.35

5.81

u/l

0.72

107

490

Complications of internal orthopaedic prosthetic devices, implants and grafts

449

1.72

4.89

1.3

1.6

5.50

6.13

u/l

0.59

369

Anankastic personality disorder

2.80

4.88

1.1

1.4

4.63

6.85

u/l

1.53

Unspecified misadventure during surgical and medical care

106

2.57

4.88

1.4

1.5

6.43

7.82

u/l

0.36

Intracranial injury

202

1374

1.39

4.88

1.7

1.4

7.66

5.89

u/l

0.72

176

1154

Other and unspecified disorders of vitreous body

149

1003

1.47

4.83

1.6

1.5

4.97

6.02

u/l

2.55

128

839

Disorders of synovium and tendon in diseases classified elsewhere

4.89

4.82

1.5

1.3

3.92

5.38

u/l

2.04

Other CVD (FINNGEN)

138

2.20

4.82

1.7

1.3

11.72

6.42

u/l

0.63

115

Transplanted organ and tissue status

215

2.06

4.81

2.0

1.5

5.81

7.13

u/l

0.67

182

Skin changes due to chronic exposure to nonionizing radiation

120

723

1.53

4.77

1.7

1.5

5.25

6.33

u/l

1.70

592

Insulin, intermediate and long-acting

188

1305

1.40

4.76

1.5

1.4

7.84

6.12

u/l

0.75

151

1104

Dislocation, sprain and strain of joints and ligaments of knee

222

1502

1.36

4.73

1.5

1.4

5.77

5.80

u/l

0.02

199

1262

Other viral diseases, not elsewhere classified

102

643

1.58

4.69

1.6

1.5

5.60

6.00

u/l

0.41

559

Substance abuse, excluding more controls

179

1081

1.41

4.67

1.3

1.4

7.62

5.96

u/l

0.63

151

913

Biomechanical lesions, not elsewhere classified

2.60

4.64

2.4

1.5

5.75

6.47

u/l

0.31

Injuries to the shoulder and upper arm

298

1842

1.30

4.62

1.6

1.4

5.60

6.04

u/l

0.63

258

1547

Persons encountering health services in circumstances related to reproduction

216

1060

1.37

4.62

1.4

1.5

5.47

6.28

u/l

1.36

190

906

Peripheral artery disease

133

709

1.50

4.62

1.7

1.5

7.50

6.35

u/l

0.32

111

583

Benign paroxysmal vertigo

105

674

1.56

4.59

1.4

1.5

6.88

6.19

u/l

0.29

564

Noninfectious colitis NAS

296

1.87

4.58

1.9

1.4

5.31

6.30

u/l

0.79

254

Other disorders of bone

473

1.68

4.58

1.4

1.5

5.21

6.31

u/l

1.33

404

Unspecified kidney failure

160

2.20

4.55

1.9

1.4

7.41

6.12

u/l

0.34

139

Personality disorders

108

700

1.55

4.53

1.2

1.5

6.53

6.05

u/l

0.14

598

Other/unspecified reactive arthropathies

135

2.31

4.52

1.4

1.5

5.84

7.49

u/l

0.65

114

Persons encountering health services for specific procedures, not carried out

167

2.17

4.52

1.4

1.3

5.21

6.06

u/l

0.86

146

COPD (mode)

405

1.65

4.52

1.4

9.94

6.53

u/l

0.58

351

Benign neoplasm of other and unspecified endocrine glands

284

1.87

4.49

1.2

1.6

11.76

6.19

u/l

0.70

245

Ankylosing spondylitis, ICD10

201

2.05

4.48

1.6

1.5

4.56

7.93

u/l

2.53

170

Disorders of vitreous body

172

1183

1.41

4.46

1.5

5.10

6.22

u/l

2.69

148

989

Viral and other specified intestinal infections

586

1.58

4.45

1.5

1.6

4.81

6.21

u/l

2.66

498

Other retinal disorders

213

1219

1.36

4.45

1.5

1.4

5.22

6.15

u/l

2.54

175

1018

Disorders of vitreous body and globe

175

1203

1.40

4.41

1.5

5.10

6.21

u/l

2.71

149

1005

Cardiomyopathy

344

1.78

4.39

1.8

1.5

9.40

5.95

u/l

0.53

286

Senile cataract

211

945

1.37

4.38

1.5

1.4

5.68

5.93

u/l

0.28

177

785

Spirochaetal infections, other/unspecified

183

2.09

4.36

1.1

1.6

5.10

7.26

u/l

1.30

157

Endometriosis ASRM stages 1,2

442

1.68

4.35

1.3

1.5

4.56

5.14

u/l

1.38

381

Benign neoplasm: Colon, unspecified

534

1.62

4.35

1.7

1.5

5.48

6.27

u/l

0.96

450

False labour

115

468

1.54

4.35

1.2

1.5

4.74

5.42

u/l

1.44

102

386

Appendectomy

240

1731

1.33

4.33

1.4

1.5

5.44

5.85

u/l

0.68

203

1461

Other diseases of anus and rectum

596

1.58

4.31

1.6

1.5

6.03

6.51

u/l

0.26

500

Persons with potential health hazards related to communicable diseases

139

951

1.45

4.31

1.5

5.20

5.85

u/l

0.65

114

814

Fracture of foot, except ankle

582

1.59

4.31

1.5

6.44

5.97

u/l

0.17

492

Care involving dialysis

151

2.20

4.30

1.7

1.4

4.87

6.37

u/l

1.36

134

Periodontitis

348

1834

1.27

4.30

1.5

1.4

5.77

6.01

u/l

0.26

302

1534

Chronic laryngitis and laryngotracheitis

267

1.88

4.29

1.4

1.5

6.01

6.32

u/l

0.15

228

Chronic periodontitis, including avohilmo

347

1833

1.27

4.28

1.5

1.4

5.76

6.01

u/l

0.28

301

1533

Arthropod-borne viral fevers and viral haemorrhagic fevers

406

1.70

4.28

1.2

1.5

5.07

6.44

u/l

1.64

346

Dental pulpitis, including avohilmo

341

1741

1.27

4.26

1.4

1.5

5.39

5.93

u/l

0.93

289

1467

Other strabismus

512

1.62

4.25

1.3

1.5

4.95

6.11

u/l

1.73

443

Familial hypercholesterolemia

247

1.91

4.23

1.3

1.5

12.12

6.21

u/l

0.60

203

Fracture of skull and facial bones

507

1.62

4.23

1.6

1.4

6.26

6.20

u/l

0.02

443

Insulin, fast-acting

126

857

1.47

4.22

1.5

8.42

5.79

u/l

0.88

102

732

Heartburn

199

2.02

4.21

1.2

1.4

4.57

6.88

u/l

1.63

168

Other noninflammatory disorders of vulva and perineum

179

2.08

4.20

1.2

1.5

4.88

6.60

u/l

1.10

154

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aldolase [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS